Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2992)
All Articles published online
|
Oct 14, 2009 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yoshikawa I, Nagato M, Yamasaki M, Kume K, Otsuki M. Long-term treatment with proton pump inhibitor is associated with undesired weight gain. World J Gastroenterol 2009; 15(38): 4794-4798 [PMID: 19824113 DOI: 10.3748/wjg.15.4794] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i38/4794.htm |
| Number | Citing Articles |
| 1 |
Jérémie Thereaux, Thomas Lesuffleur, Sébastien Czernichow, Arnaud Basdevant, Simon Msika, David Nocca, Bertrand Millat, Anne Fagot-Campagna. Do sleeve gastrectomy and gastric bypass influence treatment with proton pump inhibitors 4 years after surgery? A nationwide cohort. Surgery for Obesity and Related Diseases 2017; 13(6): 951 doi: 10.1016/j.soard.2016.12.013
|
| 2 |
Chih-Chia Liang, I.-Kuan Wang, Hsin-Hung Lin, Hung-Chieh Yeh, Jiung-Hsiun Liu, Huey-Liang Kuo, Wei-Min Hsu, Chiu-Ching Huang, Chiz-Tzung Chang. Prophylactic Use of Omeprazole Associated with a Reduced Risk of Peptic Ulcer Disease Among Maintenance Hemodialysis Patients. Renal Failure 2011; 33(3): 323 doi: 10.3109/0886022X.2011.560407
|
| 3 |
Janaina Luz Narciso-Schiavon, Leonardo Lucca Schiavon. Fatty liver and celiac disease: Why worry?. World Journal of Hepatology 2023; 15(5): 666-674 doi: 10.4254/wjh.v15.i5.666
|
| 4 |
Mesut Savas, Vincent L. Wester, Jenny A. Visser, Lotte Kleinendorst, Bert van der Zwaag, Mieke M. van Haelst, Erica L.T. van den Akker, Elisabeth F.C. van Rossum. Extensive Phenotyping for Potential Weight-Inducing Factors in an Outpatient Population with Obesity. Obesity Facts 2019; 12(4): 369 doi: 10.1159/000499978
|
| 5 |
Peter Fentz Haastrup, Dorte Ejg Jarbøl, Wade Thompson, Jane Møller Hansen, Jens Søndergaard, Sanne Rasmussen. When does proton pump inhibitor treatment become long term? A scoping review. BMJ Open Gastroenterology 2021; 8(1): e000563 doi: 10.1136/bmjgast-2020-000563
|
| 6 |
Yu-Fong Syu, Hsien-Hao Huang, Chih-Yen Chen. Do Proton Pump Inhibitors Contribute to Weight Gain?. Obesity Surgery 2015; 25(6): 1071 doi: 10.1007/s11695-015-1659-x
|
| 7 |
Itay Amir, Fred M. Konikoff, Michal Oppenheim, Uri Gophna, Elizabeth E. Half. Gastric microbiota is altered in oesophagitis and Barrett's oesophagus and further modified by proton pump inhibitors. Environmental Microbiology 2014; 16(9): 2905 doi: 10.1111/1462-2920.12285
|
| 8 |
Katharina Schnabl, Yongguo Li, Martin Klingenspor. The gut hormone secretin triggers a gut–brown fat–brain axis in the control of food intake. Experimental Physiology 2020; 105(8): 1206 doi: 10.1113/EP087878
|
| 9 |
Jonathan R. Zadeh, Rafael Alvarez, Leena Khaitan, Mujjahid Abbas. Conversion of gastric sleeve to Roux-en-Y gastric bypass: overall outcomes and predictors of below-average weight loss. Surgery for Obesity and Related Diseases 2023; 19(2): 111 doi: 10.1016/j.soard.2022.10.029
|
| 10 |
Jessica A. Davis, Fiona Collier, Mohammadreza Mohebbi, Amanda L. Stuart, Amy Loughman, Julie A. Pasco, Felice N. Jacka. Obesity, Akkermansia muciniphila, and Proton Pump Inhibitors: Is there a Link?. Obesity Research & Clinical Practice 2020; 14(6): 524 doi: 10.1016/j.orcp.2020.10.006
|
| 11 |
Mubin I. Syed, Kamal Morar, Azim Shaikh, Paul Craig, Omar Khan, Sumeet Patel, Hooman Khabiri. Gastric Artery Embolization Trial for the Lessening of Appetite Nonsurgically (GET LEAN): Six-Month Preliminary Data. Journal of Vascular and Interventional Radiology 2016; 27(10): 1502 doi: 10.1016/j.jvir.2016.07.010
|
| 12 |
Jing Chen, Lihong Chen, Philippe Sanseau, Johannes M. Freudenberg, Deepak K. Rajpal. Significant obesity-associated gene expression changes occur in the stomach but not intestines in obese mice. Physiological Reports 2016; 4(10): e12793 doi: 10.14814/phy2.12793
|
| 13 |
Milena Saqui-Salces, Amy C. Tsao, Merritt G. Gillilland, Juanita L. Merchant. Weight gain in mice on a high caloric diet and chronically treated with omeprazole depends on sex and genetic background. American Journal of Physiology-Gastrointestinal and Liver Physiology 2017; 312(1): G15 doi: 10.1152/ajpgi.00211.2016
|
| 14 |
Emily K. Ward, Dara P. Schuster, Katie H. Stowers, Amanda K. Royse, Diana Ir, Charles E. Robertson, Daniel N. Frank, Gregory L. Austin. The Effect of PPI Use on Human Gut Microbiota and Weight Loss in Patients Undergoing Laparoscopic Roux-en-Y Gastric Bypass. Obesity Surgery 2014; 24(9): 1567 doi: 10.1007/s11695-014-1275-1
|
| 15 |
Emily K. Ward, Elsbeth Jensen-Otsu, Jonathon A. Schoen, Kevin Rothchild, Breana Mitchell, Gregory L. Austin. Acid suppression medications are associated with suboptimal weight loss after laparoscopic Roux-en-Y gastric bypass in patients older than 40 years. Surgery for Obesity and Related Diseases 2015; 11(3): 585 doi: 10.1016/j.soard.2014.09.027
|
| 16 |
Hsien-Hao Huang, Harn-Shen Chen, Chih-Yen Chen. Association of short-term proton pump inhibitor therapy with weight gain in patients older than 40 years with gastric ulcer. Surgery for Obesity and Related Diseases 2015; 11(5): 1187 doi: 10.1016/j.soard.2015.05.013
|
| 17 |
Current Management of Obesity in an Infertile Female-Recent Advances and Future Prospective Drugs. Journal of Pharmacy and Nutrition Sciences 2013; 3(3): 178 doi: 10.6000/1927-5951.2013.03.03.2
|
| 18 |
Eline S. van der Valk, Erica L.T. van den Akker, Mesut Savas, Lotte Kleinendorst, Jenny A. Visser, Mieke M. Van Haelst, Arya M. Sharma, Elisabeth F.C. van Rossum. A comprehensive diagnostic approach to detect underlying causes of obesity in adults. Obesity Reviews 2019; 20(6): 795 doi: 10.1111/obr.12836
|
| 19 |
Jinqiu Yuan, Qiangsheng He, Long H Nguyen, Martin C S Wong, Junjie Huang, Yuanyuan Yu, Bin Xia, Yan Tang, Yulong He, Changhua Zhang. Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies. Gut 2021; 70(6): 1070 doi: 10.1136/gutjnl-2020-322557
|
| 20 |
Yuan Bin Liu, Ming Kai Chen. The impact of proton pump inhibitors in liver diseases and the effects on the liver. Journal of Digestive Diseases 2022; 23(4): 196 doi: 10.1111/1751-2980.13093
|
| 21 |
Nicola Imperatore, Raffaella Tortora, Anna Testa, Nicolò Gerbino, Nicola Caporaso, Antonio Rispo. Proton pump inhibitors as risk factor for metabolic syndrome and hepatic steatosis in coeliac disease patients on gluten-free diet. Journal of Gastroenterology 2018; 53(4): 507 doi: 10.1007/s00535-017-1381-7
|
| 22 |
Wei-Sheng Lin, Cheng-Wen Huang, You-Sheng Song, Jui-Hung Yen, Ping-Chang Kuo, Sheng-Rong Yeh, Hung-Yu Lin, Tsai-Feng Fu, Ming-Shiang Wu, Horng-Dar Wang, Pei-Yu Wang, Chih-Pin Chuu. Reduced Gut Acidity Induces an Obese-Like Phenotype in Drosophila melanogaster and in Mice. PLOS ONE 2015; 10(10): e0139722 doi: 10.1371/journal.pone.0139722
|
| 23 |
Jennifer Czwornog, Gregory Austin. Association of Proton Pump Inhibitor (PPI) Use with Energy Intake, Physical Activity, and Weight Gain. Nutrients 2015; 7(10): 8592 doi: 10.3390/nu7105416
|
| 24 |
C Menni, M A Jackson, T Pallister, C J Steves, T D Spector, A M Valdes. Gut microbiome diversity and high-fibre intake are related to lower long-term weight gain. International Journal of Obesity 2017; 41(7): 1099 doi: 10.1038/ijo.2017.66
|